CRISPR Therapeutics AG (CRSP) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to $95.9 million.
- CRISPR Therapeutics AG's Shares Outstanding rose 1184.06% to $95.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $95.9 million, marking a year-over-year increase of 1184.06%. This contributed to the annual value of $95.9 million for FY2025, which is 1184.06% up from last year.
- Per CRISPR Therapeutics AG's latest filing, its Shares Outstanding stood at $95.9 million for Q4 2025, which was up 1184.06% from $93.9 million recorded in Q3 2025.
- CRISPR Therapeutics AG's Shares Outstanding's 5-year high stood at $95.9 million during Q4 2025, with a 5-year trough of $75.7 million in Q1 2021.
- In the last 5 years, CRISPR Therapeutics AG's Shares Outstanding had a median value of $79.4 million in 2023 and averaged $82.0 million.
- Per our database at Business Quant, CRISPR Therapeutics AG's Shares Outstanding surged by 2437.28% in 2021 and then surged by 150.66% in 2023.
- Quarter analysis of 5 years shows CRISPR Therapeutics AG's Shares Outstanding stood at $77.0 million in 2021, then rose by 1.98% to $78.5 million in 2022, then rose by 1.95% to $80.0 million in 2023, then increased by 7.12% to $85.7 million in 2024, then increased by 11.84% to $95.9 million in 2025.
- Its Shares Outstanding was $95.9 million in Q4 2025, compared to $93.9 million in Q3 2025 and $88.4 million in Q2 2025.